Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million
RXRX•Q2 operating results
Aug 05 (Reuters) - Recursion Pharmaceuticals Q2 pretax profit USD -131.006 million.
- Q2 operating income USD -134.968 million
- Q2 net income USD -131.005 million
